1. Home
  2. TVTX vs SBLK Comparison

TVTX vs SBLK Comparison

Compare TVTX & SBLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • SBLK
  • Stock Information
  • Founded
  • TVTX 2008
  • SBLK 2006
  • Country
  • TVTX United States
  • SBLK Greece
  • Employees
  • TVTX N/A
  • SBLK N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • SBLK Marine Transportation
  • Sector
  • TVTX Health Care
  • SBLK Consumer Discretionary
  • Exchange
  • TVTX Nasdaq
  • SBLK Nasdaq
  • Market Cap
  • TVTX 1.9B
  • SBLK 1.9B
  • IPO Year
  • TVTX N/A
  • SBLK N/A
  • Fundamental
  • Price
  • TVTX $17.44
  • SBLK $15.72
  • Analyst Decision
  • TVTX Strong Buy
  • SBLK Strong Buy
  • Analyst Count
  • TVTX 13
  • SBLK 3
  • Target Price
  • TVTX $33.08
  • SBLK $22.67
  • AVG Volume (30 Days)
  • TVTX 1.5M
  • SBLK 2.2M
  • Earning Date
  • TVTX 05-05-2025
  • SBLK 05-21-2025
  • Dividend Yield
  • TVTX N/A
  • SBLK 13.61%
  • EPS Growth
  • TVTX N/A
  • SBLK 60.00
  • EPS
  • TVTX N/A
  • SBLK 2.80
  • Revenue
  • TVTX $233,175,000.00
  • SBLK $1,265,458,000.00
  • Revenue This Year
  • TVTX $71.39
  • SBLK N/A
  • Revenue Next Year
  • TVTX $55.24
  • SBLK $18.23
  • P/E Ratio
  • TVTX N/A
  • SBLK $5.56
  • Revenue Growth
  • TVTX 60.55
  • SBLK 33.31
  • 52 Week Low
  • TVTX $5.12
  • SBLK $14.30
  • 52 Week High
  • TVTX $25.29
  • SBLK $27.47
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 34.91
  • SBLK 45.20
  • Support Level
  • TVTX $20.29
  • SBLK $15.24
  • Resistance Level
  • TVTX $20.98
  • SBLK $16.22
  • Average True Range (ATR)
  • TVTX 1.00
  • SBLK 0.45
  • MACD
  • TVTX -0.23
  • SBLK -0.13
  • Stochastic Oscillator
  • TVTX 2.01
  • SBLK 22.86

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About SBLK Star Bulk Carriers Corp.

Star Bulk Carriers Corp provides seaborne transportation solutions in the dry bulk sector. The company owns and operates dry bulk carrier vessels, which are used to transport bulk, such as iron ore, coal, grains, bauxite, fertilizers, and steel products. It owns a fleet of vessels that consists of Newcastlemax, Capesize, Post Panamax, Kamsarmax, Panamax, Ultramax, and Supramax. It generates revenues through the voyages it carries out.

Share on Social Networks: